UZBEKISTAN/INDIA: In a recent development, the World Health Organisation (WHO) issued recommendations to avoid consuming the two alleged cough syrups manufactured by the Noida-based, Marion Biotech company. The medical experts called the syrups ‘substandard medical products’, which fail to match the quality standards or specifications that are required.
Uzbekistan recorded several deaths on December 22, 2022, as a result of the consumption of India-based cough syrups AMBRONOL syrup and DOK-1 Max syrup.
Amid the ongoing emergency, the WHO laboratory analysed the samples of the cough syrups, undertaken by the national quality control laboratories of the Ministry of Health of the Republic of Uzbekistan. The results were shocking, as the research claimed that they found amounts of diethylene glycol and ethylene glycol as contaminants.
“Both of these products may have marketing authorizations in other countries in the region. They may also have been distributed, through informal markets, to other countries or regions”, said WHO.
The agency further added, “The substandard products referenced in this alert are unsafe, and their use, especially in children, may result in serious injury or death.”
The ignorance of health took away the lives of 18 children in Uzbekistan. Following that, on Tuesday, the Uttar Pradesh Food Safety and Drug Administration department suspended the production license of Marion Biotech company.
The concerned officials asked the company to respond to a ‘show cause’ within seven days; however, they failed to inform the authorities on the given days. Thus, they received a notice on December 30.
The Gautam Buddh Nagar Drug Inspector Vaibhav Babbar, informing the public of the current action against the company, said, “We have suspended the production license of Marion Biotech company after not providing enough documents, a show-cause notice was also given by the state licensing authority depending upon the documents asked during the inspection, which they didn’t provide.”